Spruce Biosciences Statistics
Total Valuation
SPRB has a market cap or net worth of $182.21 million. The enterprise value is $93.59 million.
| Market Cap | 182.21M |
| Enterprise Value | 93.59M |
Important Dates
The last earnings date was Wednesday, August 12, 2026, before market open.
| Earnings Date | Aug 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SPRB has 2.87 million shares outstanding. The number of shares has increased by 149.79% in one year.
| Current Share Class | 2.87M |
| Shares Outstanding | 2.87M |
| Shares Change (YoY) | +149.79% |
| Shares Change (QoQ) | +77.18% |
| Owned by Insiders (%) | 3.45% |
| Owned by Institutions (%) | 51.25% |
| Float | 2.02M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 2.08 |
| P/TBV Ratio | 2.18 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 9.23, with a Debt / Equity ratio of 0.09.
| Current Ratio | 9.23 |
| Quick Ratio | 8.78 |
| Debt / Equity | 0.09 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -22.23 |
Financial Efficiency
Return on equity (ROE) is -105.98% and return on invested capital (ROIC) is -46.91%.
| Return on Equity (ROE) | -105.98% |
| Return on Assets (ROA) | -40.03% |
| Return on Invested Capital (ROIC) | -46.91% |
| Return on Capital Employed (ROCE) | -43.45% |
| Weighted Average Cost of Capital (WACC) | 22.46% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.33M |
| Employee Count | 22 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +673.17% in the last 52 weeks. The beta is 3.34, so SPRB's price volatility has been higher than the market average.
| Beta (5Y) | 3.34 |
| 52-Week Price Change | +673.17% |
| 50-Day Moving Average | 49.03 |
| 200-Day Moving Average | 65.78 |
| Relative Strength Index (RSI) | 80.51 |
| Average Volume (20 Days) | 54,157 |
Short Selling Information
The latest short interest is 429,122, so 14.93% of the outstanding shares have been sold short.
| Short Interest | 429,122 |
| Short Previous Month | 415,860 |
| Short % of Shares Out | 14.93% |
| Short % of Float | 21.28% |
| Short Ratio (days to cover) | 6.66 |
Income Statement
| Revenue | n/a |
| Gross Profit | -22.95M |
| Operating Income | -39.93M |
| Pretax Income | -51.35M |
| Net Income | -51.35M |
| EBITDA | -39.04M |
| EBIT | -39.93M |
| Earnings Per Share (EPS) | -$36.05 |
Balance Sheet
The company has $96.30 million in cash and $7.67 million in debt, with a net cash position of $88.62 million or $30.84 per share.
| Cash & Cash Equivalents | 96.30M |
| Total Debt | 7.67M |
| Net Cash | 88.62M |
| Net Cash Per Share | $30.84 |
| Equity (Book Value) | 83.73M |
| Book Value Per Share | 30.42 |
| Working Capital | 90.19M |
Cash Flow
In the last 12 months, operating cash flow was -$42.62 million and capital expenditures -$145,000, giving a free cash flow of -$42.77 million.
| Operating Cash Flow | -42.62M |
| Capital Expenditures | -145,000 |
| Depreciation & Amortization | 891,000 |
| Net Borrowing | 12.90M |
| Free Cash Flow | -42.77M |
| FCF Per Share | -$14.88 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
SPRB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -149.79% |
| Shareholder Yield | -149.79% |
| Earnings Yield | -28.18% |
| FCF Yield | -23.47% |
Analyst Forecast
The average price target for SPRB is $147.88, which is 133.25% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $147.88 |
| Price Target Difference | 133.25% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on August 7, 2025. It was a reverse split with a ratio of 1:75.
| Last Split Date | Aug 7, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:75 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |